dydrogesterone has been researched along with homocysteine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blom, HJ; Eskes, TK; Rolland, R; Schellekens, LA; van der Mooren, MJ; Wouters, MG | 1 |
Jakobs, C; Kenemans, P; Mijatovic, V; Peters-Muller, ER; van Baal, WM; van der Mooren, MJ | 1 |
Jakobs, C; Kenemans, P; Mijatovic, V; Netelenbos, C; Peters-Muller, ER; Popp-Snijders, C; van der Mooren, MJ | 1 |
Kenemans, P; Smolders, RG; Teerlink, T; van Baal, WM; van der Mooren, MJ | 1 |
de Meer, K; Jakobs, C; Kenemans, P; Smolders, RG; Teerlink, T; van der Mooren, MJ | 1 |
de Kraker, AT; Kenemans, P; Kroeks, MV; Smolders, RG; van der Mooren, MJ | 1 |
5 trial(s) available for dydrogesterone and homocysteine
Article | Year |
---|---|
A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women.
Topics: Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Homocysteine; Humans; Middle Aged; Postmenopause; Treatment Outcome | 1998 |
Postmenopausal oral 17beta-estradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels.
Topics: Administration, Oral; Double-Blind Method; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Homocysteine; Humans; Middle Aged; Postmenopause; Sex Hormone-Binding Globulin | 1998 |
Hormone replacement therapy and plasma homocysteine levels.
Topics: Dydrogesterone; Estradiol; Fasting; Female; Homocysteine; Hormone Replacement Therapy; Humans; Middle Aged; Progesterone Congeners; Promegestone; Prospective Studies; Time Factors | 1999 |
Hormone replacement influences homocysteine levels in the methionine-loading test: a randomized placebo controlled trial in postmenopausal women.
Topics: Analysis of Variance; Blood Chemical Analysis; Double-Blind Method; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Folic Acid; Homocysteine; Humans; Methionine; Middle Aged; Postmenopause; Pyridoxine; Treatment Outcome; Vitamin B 12 | 2004 |
Short-term effects of two continuous combined oestrogen-progestogen therapies on several cardiovascular risk markers in healthy postmenopausal women: a randomised controlled trial.
Topics: Adult; alpha-2-Antiplasmin; Antigens; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Drug Combinations; Dydrogesterone; Endothelin-1; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Fibrinogen; Fibrinolysin; Homocysteine; Humans; Insulin-Like Growth Factor I; Medroxyprogesterone Acetate; Middle Aged; Plasminogen Activator Inhibitor 1; Postmenopause; Risk Factors; Time Factors; Tissue Plasminogen Activator | 2009 |
1 other study(ies) available for dydrogesterone and homocysteine
Article | Year |
---|---|
Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women.
Topics: Drug Administration Schedule; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Homocysteine; Humans; Middle Aged; Postmenopause; Prospective Studies | 1994 |